Tiletamine

This classification denotes an anesthetic agent with the molecular formula C12H17NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2YFC543249, chemically known as cyclohexanone, 2- (ethylamino)-2-(2-thienyl)-, hydrochloride but generally known as tiletamine, which bears US NIH Compound Identifier 26533. European Medicines Agency schedules Tiletamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11050MIG. The term TILETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). TILETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiletamine under HS 29349990 and SITC 51579. As of Q4 2014, TILETAMINE remains the US FDA Preferred Term for this commodity. Tiletamine bears US NLM identifiers UMLS ID C0040217 and NCI Concept Code C84211. SMILES: CCNC1(CCCCC1=O)C2=CC=CS2.